Ipca Laboratories Ltd. (IPCALAB) Share Price Rises 3.18% Today as Large Cap Stock Enters Top Gainers

Ipca Laboratories Ltd. traded at Rs 1,739.8, up 3.18% today, taking its market capitalisation to Rs 44,064.62 crore and placing it among the large-cap top gainers.

Ipca Laboratories Ltd. Share Price moved higher in today’s session, with the stock trading at Rs 1,739.8, up Rs 53.6 or 3.18%. At this level, the company’s market capitalisation stood at Rs 44,064.62 crore, putting the healthcare name firmly in the large-cap basket. In today’s Stock Market Today action, the move was notable enough for the stock to appear in a price-rise screen built around market-cap-based thresholds.

For investors tracking Ipca Laboratories Ltd. Share Price Today, the numbers show a session marked by strength from the open itself. The stock opened at Rs 1,671.65, also the day’s low, and then advanced to an intraday high of Rs 1,743 before holding close to those upper levels in afternoon trade. That pattern matters because it points to sustained buying interest through the day rather than a brief spike that quickly faded.

The supplied data confirms the price event, but it does not establish a company-specific catalyst behind today’s move. Even so, Ipca Laboratories Ltd. Stock News is trending because the stock delivered a meaningful single-day gain, stayed near its high, and did so as a large-cap healthcare company with a market value far above many same-sector companies in the benchmark set. Univest notes that investors will likely monitor whether this price rise is accompanied by broader participation, sector follow-through and continued relative strength against listed healthcare peers.

Ipca Laboratories Ltd. (IPCALAB) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,739.8
Previous Close	Rs 1,686.2
Today's Change	+Rs 53.6 (+3.18%)
Day Open	Rs 1,671.65
Day High	Rs 1,743
Day Low	Rs 1,671.65
Current Volume (BSE)	16,020
BSE Traded Volume	16,020
NSE Traded Volume	1,69,858
Combined NSE + BSE Volume	1,85,878
Turnover	Rs 2.79 crore
Market Capitalisation	Rs 44,064.62 crore
Market Cap Category	Large Cap

Ipca Laboratories Ltd. (IPCALAB) traded at Rs 1,739.8. versus the previous close of Rs 1,686.2, a rise of 3.18%. The stock opened at Rs 1,671.65, reached Rs 1,743, touched Rs 1,671.65. Reported volume was 16,020.

Ipca Laboratories Ltd. (IPCALAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 44,064.62 crore

Ipca Laboratories Ltd. Fundamental Analysis, based on the supplied dataset, is more about market standing and sector context than a full company financial model. The first important number is market capitalisation. At Rs 44,064.62 crore, Ipca Laboratories Ltd. is substantially larger than the typical company in the supplied Healthcare benchmark set. That benchmark covers 197 companies, with a median market capitalisation of Rs 142.3 crore and an average of Rs 472.15 crore, while the maximum listed in that same set is Rs 3,032.97 crore. On size alone, Ipca Laboratories stands apart.

That scale matters because Market Capitalisation indicates company size, market visibility and institutional relevance, not quality by itself. A large-cap stock can still move meaningfully in a single session, and today’s 3.18% rise shows that investors continue to track the name closely within broader Healthcare market updates. For readers searching Ipca Laboratories Ltd. Share Price, the combination of a large market value and a sharp same-day gain is what makes the stock relevant in today’s market news cycle.

The available numbers do not provide company-specific P/E Ratio, P/B Ratio, ROE, ROCE, EPS, Book Value, Dividend Yield, leverage or cash-flow figures for Ipca Laboratories in this workflow, so the most reliable fundamental lens here is relative positioning inside the sector benchmark and peer set. Even under that narrower lens, the stock’s scale is notable. Many benchmark companies in the same sector operate at far lower market values, which often changes how investors interpret a single-day move: for a large-cap company, a 3.18% price rise can attract more attention because it reflects a sizable change in market value in absolute terms.

Univest therefore views today’s move as fundamentally relevant not because the supplied data proves a fresh corporate trigger, but because the stock’s size, sector linkage and placement among today’s top gainers make it a company that investors may continue to monitor closely. The next useful layer is how ownership and then sector comparison frame that attention.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Benchmark Median P/E	25.7x
Benchmark Average P/E	96.66x
Benchmark P/E Range	3.08x to 3,396.3x
Benchmark Median P/B	1.94x
Benchmark Median ROE	10.92%
Benchmark Median ROCE	13.38%
Company Market Capitalisation	Rs 44,064.62 crore
Benchmark Median Market Cap	Rs 142.3 crore

Ipca Laboratories Ltd. (IPCALAB) is classified under sector: Healthcare.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

The sector backdrop places today’s move in a broader Healthcare context. Ipca Laboratories belongs to Healthcare, and the supplied benchmark spans 197 companies in the same sector, giving a useful framework for comparing market size, valuation ranges and profitability trends across listed peers.

In the Healthcare benchmark snapshot, the median P/E stands at 25.7 and the average P/E at 96.66 across 156 companies, with the range stretching from 3.08 to 3,396.3. On P/B, the median is 1.94 and the average is 2.65 across 196 companies, while the range runs from -16.9 to 15.98. Profitability markers also vary widely: median ROE is 10.92 and average ROE is 15.47 across 196 companies, while median ROCE is 13.38 and average ROCE is 17.78 across the same count.

What stands out immediately is how broad the Healthcare valuation and return distribution is. That tells investors the sector contains everything from loss-making or low-return businesses to companies carrying much richer multiples and stronger operating efficiency. In that environment, price moves often need to be read with care. A same-day gain may reflect company-specific demand, sector rotation, or relative performance within a fragmented industry structure. The supplied data confirms the gain and the sector membership, but it does not establish a named catalyst.

Where Ipca Laboratories differentiates clearly in the supplied sector dataset is market size. Its market capitalisation of Rs 44,064.62 crore is far above the benchmark median of Rs 142.3 crore, above the benchmark average of Rs 472.15 crore, and well above the maximum market cap figure shown in the benchmark company list at Rs 3,032.97 crore. That does not prove valuation or profitability superiority by itself, but it does show why Ipca Laboratories Ltd. Share Price can become a major focus in NSE News and BSE News when it enters the list of Top Gainers Today. Univest sees that size gap as a key reason the stock’s price action carries wider market relevance.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	3,032.97	0	0.76	-2.89	-0.26
Hikal Ltd.	HIKAL	2,799.54	0	2.32	15.22	16.15
Kwality Pharmaceuticals Ltd.	KPL	2,707.2	40.09	9.77	28.21	26.35
Beta Drugs Ltd.	BETA	2,631.45	66.92	10.59	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,601.85	34.14	7.04	-2.6	16.92

Ipca Laboratories Ltd. (IPCALAB) has a market capitalisation of Rs 44,064.62 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

The supplied peer set shows Ipca Laboratories in a healthcare universe where many listed companies are much smaller by market capitalisation and display sharply different valuation and profitability profiles. That contrast helps frame why today’s move in a large-cap stock is being watched so closely.

Among the named peers, Dishman Carbogen Amcis Ltd. has a market cap of Rs 3,032.97 crore, Hikal Ltd. stands at Rs 2,799.54 crore, Kwality Pharmaceuticals Ltd. at Rs 2,707.2 crore, Beta Drugs Ltd. at Rs 2,631.45 crore and Dr Agarwals Eye Hospital Ltd. at Rs 2,601.85 crore. Other peers in the set include Panacea Biotec Ltd. at Rs 2,531.49 crore, Sai Parenteral's Ltd. at Rs 2,513.58 crore, Solara Active Pharma Sciences Ltd. at Rs 2,422.79 crore, NGL Fine-Chem Ltd. at Rs 2,118.6 crore and Venus Remedies Ltd. at Rs 2,068.61 crore. Against that backdrop, Ipca Laboratories’ Rs 44,064.62 crore market cap is dramatically larger.

The peer profitability and valuation data also underline the diversity of the sector. Kwality Pharmaceuticals shows P/E of 40.09, P/B of 9.77, ROE of 28.21% and ROCE of 26.35%. Beta Drugs carries P/E of 66.92, P/B of 10.59, ROE of 18.65% and ROCE of 22.17%. NGL Fine-Chem reports P/E of 44.48, P/B of 6.5, ROE of 27.9% and ROCE of 33.91%. At the other end, Dishman Carbogen Amcis has P/B of 0.76 with ROE of -2.89% and ROCE of -0.26%, while Dr Agarwals Eye Hospital shows P/E of 34.14, P/B of 7.04, ROE of -2.6% and ROCE of 16.92%.

This peer spread matters for stock analysis because it shows investors are comparing companies across very different profitability and valuation bands even within Healthcare. Univest would read Ipca Laboratories Ltd. Share Price movement today through that lens: not as an isolated market mover, but as a large-cap name drawing attention in a sector where many peers are smaller and operational outcomes vary widely.

Why Investors Are Watching Ipca Laboratories Ltd.

Investors are watching Ipca Laboratories Ltd. because today’s move combined a meaningful percentage gain with large-cap scale. In a session where market participants often focus on market movers and momentum stocks, the stock rose 3.18%, traded close to its intraday high and qualified for a price-rise screen tied to market-cap category.

• Verified price action: The stock moved from a previous close of Rs 1,686.2 to Rs 1,739.8, a gain of Rs 53.6.
• Intraday behaviour: It opened at Rs 1,671.65, which was also the day’s low, and touched Rs 1,743.
• Participation: Total volume reached 1,85,878 shares, including 1,69,858 on NSE and 16,020 on BSE.
• Market size: Market capitalisation was Rs 44,064.62 crore, making this a closely watched large-cap move.
• Sector position: The company sits in Healthcare, a benchmark universe of 197 companies with widely dispersed valuations and returns.

What investors may monitor next is whether Ipca Laboratories Ltd. Share Price continues to hold near upper trading levels, whether sector-wide healthcare activity remains supportive, and how the stock compares with peers on subsequent market updates. Univest highlights that the price event is confirmed by the data, while the exact corporate trigger is not identified in the supplied workflow.

About Ipca Laboratories Ltd.

Ipca Laboratories Ltd. is part of the Healthcare sector, and the peer and benchmark data place it alongside companies linked mainly to Pharmaceuticals & Drugs, with one healthcare services name also appearing in the comparison set. That sector placement is important because it shapes how the market interprets daily price action, valuation benchmarks and peer positioning.

The available dataset does not provide a long-form company description, business segments or product mix, so the most factual company overview here comes from its market position within the listed healthcare universe. On that basis, Ipca Laboratories stands out as a significantly larger company than the benchmark companies listed in the supplied dataset. With a market capitalisation of Rs 44,064.62 crore, it sits far above many named sector peers whose market values range from about Rs 2,068.61 crore to Rs 3,032.97 crore.

That size suggests why Ipca Laboratories Ltd. Share Price attracts broad attention in the Indian Stock Market when it becomes one of the Stocks in News. Large-cap healthcare names can influence how traders think about sector tone, while also drawing interest from investors who track established companies rather than only smaller breakout stocks. In short, the supplied data identifies Ipca Laboratories as a major listed Healthcare company whose stock performance matters well beyond a narrow peer group, especially on a day when the share price gains 3.18%.

Track Ipca Laboratories Ltd. Share Price on Univest

Use Ipca Laboratories Ltd. (IPCALAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors following Ipca Laboratories Ltd. Share Price can use Univest to track live share price updates, day change, market capitalisation, 52-week levels, sector positioning and broader stock analysis in one place. For active market watchers, that means a single view of price action, market context and comparative signals across NSE and BSE activity.

Univest also helps users monitor stock news, peer positioning, sector benchmarks and historical market behaviour around top gainers. For a stock like Ipca Laboratories Ltd., which has entered focus after a 3.18% rise, a platform view can help investors organise today’s numbers with future market updates without turning a price event into a recommendation.

Frequently Asked Questions

Why is Ipca Laboratories Ltd. Share Price rising today?

Ans. Ipca Laboratories Ltd. Share Price was up 3.18% at Rs 1,739.8, compared with the previous close of Rs 1,686.2. The supplied data confirms the price rise and top gainer screening event, but it does not identify a specific company catalyst.

What is Ipca Laboratories Ltd. Share Price Today?

Ans. Ipca Laboratories Ltd. Share Price Today was Rs 1,739.8 at the time of the article. That represented a gain of Rs 53.6, or 3.18%, from the previous close of Rs 1,686.2 in afternoon trade on 11 August 2026.

How did Ipca Laboratories trade intraday today?

Ans. The stock opened at Rs 1,671.65, which was also the day’s low, and later rose to an intraday high of Rs 1,743. Trading near the upper end of that range indicated sustained strength during the session.

What was the total trading volume in Ipca Laboratories today?

Ans. Total traded volume stood at 1,85,878 shares. That included 1,69,858 shares on NSE and 16,020 shares on BSE, showing that the day’s price rise was accompanied by active exchange participation across both markets.

What was the turnover recorded in today’s move?

Ans. The supplied turnover figure was Rs 2.79 crore on the identified exchange snapshot. Combined with a 3.18% share price gain and trading near the intraday high, that points to a session that drew notable market attention.

What is the market capitalisation of Ipca Laboratories Ltd.?

Ans. Ipca Laboratories Ltd. had a market capitalisation of Rs 44,064.62 crore at the time of writing. That places it in the large-cap category and makes today’s 3.18% gain more visible in the broader healthcare market update.

Which sector does Ipca Laboratories belong to?

Ans. Ipca Laboratories belongs to the Healthcare sector. The supplied benchmark covers 197 companies in the same sector, making healthcare context important when assessing today’s share price rise, peer positioning and broader listed market relevance.

How large is Ipca Laboratories compared with the sector benchmark?

Ans. Ipca Laboratories is much larger than the supplied Healthcare benchmark averages. Its market cap is Rs 44,064.62 crore, versus a benchmark median of Rs 142.3 crore and average of Rs 472.15 crore across 197 companies.

Which peer companies appear in the supplied comparison set?

Ans. The supplied peer set includes Dishman Carbogen Amcis, Hikal, Kwality Pharmaceuticals, Beta Drugs, Dr Agarwals Eye Hospital, Panacea Biotec, Sai Parenteral's, Solara Active Pharma Sciences, NGL Fine-Chem and Venus Remedies, all from the Healthcare space.

Why is this stock move getting attention in market news?

Ans. The move is getting attention because Ipca Laboratories is a large-cap healthcare company and the stock rose 3.18% in one session. It also traded close to its day’s high, which often keeps a stock in focus among top gainers.